Top Abstract Purchase Related
Home
>
Node
>
Subnode

Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone

Ohashi, H.; Ichikawa, A.; Takagi, N.; Hotta, T.; Naoe, T.; Ohno, R.; Saito, H.

Leukemia 6(8): 859-862

1992

ISSN/ISBN: 0887-6924
PMID: 1353552
Document Number: 400773
Sequential molecular and cellular changes during remission induction were investigated in a case of acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA). By means of clonality analysis, the assessment of the retinoic acid receptor alpha gene alterations, as well as conventional cytologic studies, it was demonstrated that remission induction of APL by ATRA proceeds in two steps: first, the differentiation of the leukemic clone to mature granulocytes and its subsequent extinction; second, proliferation/differentiation of the residual normal clones to restore polyclonal hematopoiesis.

Document emailed within 1 workday
Secure & encrypted payments

Cornic, M.; Delva, L.; Castaigne, S.; Lefebvre, P.; Balitrand, N.; Degos, L.; Chomienne, C. 1994: In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia Leukemia 8(Suppl): S16-S19
Watanabe, R.; Murata, M.; Takayama, N.; Tokuhira, M.; Kizaki, M.; Okamoto, S.; Kawai, Y.; Watanabe, K.; Murakami, H.; Kikuchi, M.; Nakamura, S.; Ikeda, Y. 1997: Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS) Thrombosis and Haemostasis 77(4): 641-645
Drach, J.; Lopez-Berestein, G.; McQueen, T.; Andreeff, M.; Mehta, K. 1993: Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid Cancer Research 53(9): 2100-2104
Ohno, R.; Naoe, T.; Fukutani, H. 1993: Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(8): 1016-1021
Wang, X.W.; Ying, J.S.; Xu, W.Z. 1992: A laboratory and clinical study of induced differentiation therapy by all trans-retinoic acid in acute promyelocytic leukemia Zhonghua Nei Ke Za Zhi 31(4): 236-240; 256
Fukutani, H.; Naoe, T.; Ohno, R.; Yoshida, H.; Miyawaki, S.; Shimazaki, C.; Miyake, T.; Nakayama, Y.; Kobayashi, H.; Goto, S. 1995: Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. the Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) Leukemia 9(9): 1478-1482
Liang, Y.; Song, W.-x.; Wang, J.; Jing, L.-p.; Qu, W.; Fu, R.; Wu, X.-z. 2005: A study on the cell differentiation induced by tanshinone IIA and its molecular mechanism in retinoic acid: resistant acute promyelocytic leukemia Zhonghua Nei Ke Za Zhi 44(5): 366-369
Zeng, H.; Zhang, X.; Chen, Z. 1998: Expression and significance of interleukin 6, interleukin 8 and their receptors in acute promyelocytic leukemia during all-trans retinoic acid induction treatment Zhonghua Zhong Liu Za Zhi 20(5): 357-360
Huang, M.E. 1988: Treatment of acute promyelocytic leukemia with all-trans retinoic acid Zhonghua Yi Xue Za Zhi 68(3): 131-133; 10
Paukovits, J.B.; Paukovits, W.R.; Laerum, O.D. 1986: Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid Cancer Research 46(9): 4444-4448
Maschan, A.A.; Klebanova, N.G.; Miakova, N.V.; Tiganova, O.A.; Timakov, A.M.; Samochatova, E.V. 1996: Treatment of acute promyelocytic leukemia in children with all-trans-retinoic acid Gematologiia i Transfuziologiia 41(2): 43-45
Wang, Z.Y.; Sun, G.L.; Lu, J.X.; Gu, L.J.; Huang, M.E.; Chen, S.R. 1990: Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China Nouvelle Revue Francaise d'Hematologie 32(1): 34-36
Sun, G.L.; Ouyang, R.R.; Chen, S.J.; Gu, Y.Z.; Huang, L.A.; Lu, J.X.; Wang, Z.Y. 1993: Treatment of acute promyelocytic leukemia with all-trans retinoic acid. a five-year experience Chinese Medical Journal 106(10): 743-748
Dubois, C.; Schlageter, M.H.; de Gentile, A.; Balitrand, N.; Toubert, M.E.; Krawice, I.; Fenaux, P.; Castaigne, S.; Najean, Y.; Degos, L. 1994: Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia Leukemia 8(10): 1750-1757
Tallman, M.S. 1994: All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies Seminars in Hematology 31(4 Suppl 5: 38-48
Chen, G.Q.; Shen, Z.X.; Wu, F.; Han, J.Y.; Miao, J.M.; Zhong, H.J.; Li, X.S.; Zhao, J.Q.; Zhu, J.; Fang, Z.W.; Chen, S.J.; Chen, Z.; Wang, Z.Y. 1996: Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia Leukemia 10(5): 825-828
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Sun, G.L. 1993: Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience Zhonghua Zhong Liu Za Zhi 15(2): 125-129
Hatake, K.; Uwai, M.; Ohtsuki, T.; Tomizuka, H.; Izumi, T.; Yoshida, M.; Miura, Y. 1997: Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management International Journal of Hematology 66(1): 13-19
Simzar, S.; Rotunda, A.M.; Craft, N. 2005: Scrotal ulceration as a consequence of all-trans-retinoic acid (ATRA) for the treatment of acute promyelocytic leukemia Journal of Drugs in Dermatology: Jdd 4(2): 231-232